Absorption and excretion of metronidazole. II. Studies on primary failures.
作者信息
KANE P O, McFADZEAN J A, SQUIRES S
出版信息
Br J Vener Dis. 1961 Dec;37(4):276-7. doi: 10.1136/sti.37.4.276.
Abstract
摘要
相似文献
1
Absorption and excretion of metronidazole. II. Studies on primary failures.
Br J Vener Dis. 1961 Dec;37(4):276-7. doi: 10.1136/sti.37.4.276.
2
Absorption and excretion of metronidazole. I. Serum concentration and urinary excretion after oral administration.
Br J Vener Dis. 1961 Dec;37(4):273-5. doi: 10.1136/sti.37.4.273.
3
Flagyl in treatment of "Trichomonas vaginalis" vaginitis.
Obstet Gynecol. 1962 May;19:595-8.
4
Flagyl in the treatment of trichomonal vaginitis.
West J Surg Obstet Gynecol. 1962 Mar-Apr;70:89-91.
5
Flagyl (metronidazole).
Br J Vener Dis. 1960 Sep;36(3):154-62. doi: 10.1136/sti.36.3.154.
6
Treatment of trichomoniasis with metronidazole.
Br Med J. 1960 Sep 24;2(5203):910-1. doi: 10.1136/bmj.2.5203.910.
7
Use of metronidazole in the treatment of trichomoniasis.
Am J Obstet Gynecol. 1962 May 15;83:1284-7. doi: 10.1016/s0002-9378(16)36036-7.
8
9
Clinical evaluation of metronidazole. A new systemic trichomonacide.
Br Med J. 1960 Sep 24;2(5203):902-5. doi: 10.1136/bmj.2.5203.902.
10
Metronidazole treatment of trichomoniasis in the female. Report of an extended trial.
Br Med J. 1962 Feb 3;1(5274):276-9. doi: 10.1136/bmj.1.5274.276.
引用本文的文献
1
Potentiating Metronidazole Scaffold against Resistant Trichomonas: Design, Synthesis, Biology and 3D-QSAR Analysis.
ACS Med Chem Lett. 2011 Dec 16;3(2):83-7. doi: 10.1021/ml200161t. eCollection 2012 Feb 9.
2
Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Clin Microbiol Rev. 2004 Oct;17(4):783-93, table of contents. doi: 10.1128/CMR.17.4.783-793.2004.
3
LONG-TERM ASPECT OF TREATMENT WITH METRONIDAZOLE (FLAGYL) IN TRICHOMONAL VAGINITIS.
Br J Vener Dis. 1963 Dec;39(4):258-60. doi: 10.1136/sti.39.4.258.
4
Strain sensitivity of Trichomonas vaginalis to metronidazole.
Br J Vener Dis. 1962 Dec;38(4):218-9. doi: 10.1136/sti.38.4.218.
5
Clinical and microbiological aspects of Trichomonas vaginalis.
Clin Microbiol Rev. 1998 Apr;11(2):300-17. doi: 10.1128/CMR.11.2.300.
6
An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV test.
Genitourin Med. 1996 Apr;72(2):132-5. doi: 10.1136/sti.72.2.132.
7
Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.
Br J Vener Dis. 1982 Dec;58(6):394-9. doi: 10.1136/sti.58.6.394.
8
Nitrimidazine compared with metronidazole in the treatment of vaginal trichomoniasis.
Br Med J. 1971 Oct 16;4(5780):146-7. doi: 10.1136/bmj.4.5780.146.
9
Persistent Trichomonas vaginalis infection due to a metronidazole-resistant strain.
CMAJ. 1986 Jun 15;134(12):1373-4.
10
Treatment of trichomoniasis in females with and without gonorrhoea.
Br J Vener Dis. 1976 Aug;52(4):276-8. doi: 10.1136/sti.52.4.276.
本文引用的文献
1
Absorption and excretion of metronidazole. I. Serum concentration and urinary excretion after oral administration.
Br J Vener Dis. 1961 Dec;37(4):273-5. doi: 10.1136/sti.37.4.273.
2
[Results of treatment with the imidazole derivative Clont in trichomoniasis in man].
Dtsch Med Wochenschr. 1961 Jun 9;86:1130-2. doi: 10.1055/s-0028-1112910.
Zotero 插件